Among the GLP-1 agonists, liraglutide is now available as a generic, but its taken once daily instead of once weekly
FDA approval of Zepbound was based on results from the phase 3 SURMOUNT-1 (adults with obesity or overweight and without type 2 diabetes) and SURMOUNT-2 (adults with obesity or overweight and with type 2 diabetes) trials which both demonstrated a statistically significant reduction in body weight compared to those who received placebo after 72 weeks of treatment
Coskun or Eli Lilly and Company, and this information does not constitute an endorsement of any products or services
to estimate insulin sensitivity in patients treated with placebo, TZP or semaglutide after 28 weeks of treatment, achieving a hyperinsulinemic, euglycemic clamp experiment, followed by a hyperglycemic clamp (216 mg/dL) to estimate insulin secretory responses
they can cause microtrauma that can lead to persistent lumps and itchy nodules
If you ever notice that your medicine looks cloudy, has floating bits in it, or is a different color, you should not use it